Any feedback?
No. of entries
Information on EC 3.1.3.86 - phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase
for references in articles please use BRENDA:EC3.1.3.86
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree 3 Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.86 phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase
IUBMB Comments
This enzyme hydrolyses 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. The enzyme also shows activity toward (PtdIns(1,3,4,5)P4) . The enzyme is involved in several signal transduction pathways in the immune system leading to an adverse range of effects.
The enzyme appears in viruses and cellular organisms
- 3.1.3.86
- phosphatases
- 3-kinase
- phosphoinositide
-
5\'-inositol
-
tyrosine-based
-
immunoreceptor
-
5'-phosphatase
-
ptdins3,4,5p3
- syk
-
tyrosine-phosphorylated
- grb2
-
pomerania
-
fcgammariib
-
phosphatase-like
- sorl1
- 3,4-bisphosphate
-
picalm
- fcepsilonri
-
ptdins3,4p2
-
microrna-155
- trem2
-
fermt2
- medicine
Reaction Schemes
showSynonyms
ship-1, ship-2, inpp5d, inppl1, 5'-inositol phosphatase, sh2-containing inositol phosphatase, sh2 domain-containing inositol 5-phosphatase, ptdins(3,4,5)p3 5-phosphatase, phosphatidylinositol 5-phosphatase, pi 5-phosphatase, more
topPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYNONYM 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
PtdIns(3,4,5)P3 5-phosphatase
SH2-containing inositol phosphatase
SHIP
SHIP-1
SHIP1
SHIP2
Src homology 2 domain-containing inositol 5-phosphatase 1
SHIP2
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REACTION
REACTION DIAGRAM
COMMENTARY
ORGANISM
UNIPROT
LITERATURE
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O = 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SYSTEMATIC NAME
IUBMB Comments
1-phosphatidyl-1D-myo-inositol-3,4,5-trisphosphate 5-phosphohydrolase
This enzyme hydrolyses 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. The enzyme also shows activity toward (PtdIns(1,3,4,5)P4) [5]. The enzyme is involved in several signal transduction pathways in the immune system leading to an adverse range of effects.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBSTRATE
PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
LITERATURE
COMMENTARY
Reversibility
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
phosphatidylinositol 4,5-bisphosphate + H2O
phosphatidylinositol 4-phosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
Substrates: substrate of isoform SHIP1 in vitro
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: substrate of isoforms SHIP2 and SHIP1 in vitro
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: in vivo substrate of SHIP2
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: in vitro substrate of SHIP2
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: preferred substrate
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: best substrate
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
inositol 1,3,4,5-tetrakisphosphate + H2O
?
-
Substrates: in vitro substrate of SHIP2
Products: -
Products: -
?
additional information
?
-
Substrates: SHIP2 does not hydrolyze 1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate in vitro
Products: -
Products: -
?
additional information
?
-
Substrates: SHIP2 does not hydrolyze 1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate in vitro
Products: -
Products: -
?
additional information
?
-
-
Substrates: cytosolic Ptdlns(3,4,5)P3 5-phosphatase which associates with phosphoinositide 3-kinase does not metabolize phosphatidylinositol 4,5-bisphosphate, inositol 1,4,5-trisphosphate or inositol 1,3,4,5-tetraphosphate
Products: -
Products: -
?
additional information
?
-
-
Substrates: synaptojanin accounts for the major part of the active PtdIns(3,4,5)P3 5-phosphatase activity in rat brain
Products: -
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
LITERATURE
COMMENTARY
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
r=reversible
ir=irreversible
?=not specified
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
Substrates: substrate of isoform SHIP1 in vitro
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 1,3,4-trisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: substrate of isoforms SHIP2 and SHIP1 in vitro
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: in vivo substrate of SHIP2
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: preferred substrate
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
Substrates: -
Products: -
Products: -
?
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + H2O
1-phosphatidyl-1D-myo-inositol 4-phosphate + phosphate
-
Substrates: -
Products: -
Products: -
?
additional information
?
-
Substrates: SHIP2 does not hydrolyze 1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate in vitro
Products: -
Products: -
?
additional information
?
-
Substrates: SHIP2 does not hydrolyze 1-phosphatidyl-1D-myo-inositol 1,3,4,5-tetrakisphosphate in vitro
Products: -
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Mg2+
additional information
-
Zn2+, Ca2+ and Mn2+ do not support enzyme activity
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
(2R)-2-[(S)-hydroxy(2-phenylbenzo[h]quinolin-4-yl)methyl]piperidin-1-ium
-
(2R)-2-[(S)-[5,7-dichloro-3-adamantyl)naphthalen-1-yl](hydroxy)methyl]piperidin-1-ium
-
2-(1-(2,4-dichlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-(1-benzyl-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
-
2-[1-(2,4-dichlorobenzyl)-2-methyl-5-(methylmercapto)-1H-indol-3-yl] ethanaminium chloride
-
2-[1-(2-chlorobenzyl)-2-methyl-5-(methylmercapto)-1H-indol-3-yl] ethanaminium chloride
-
2-[1-[(2,4-dichlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
40% inhibition at 0.5 mM
2-[1-[(2-chlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
-
3-[(2,4-dichlorophenyl)methoxy]-N-[(2,6-difluorophenyl)methyl]thiophene-2-carboxamide
AS1938909, competitive inhibitor of SHIP2
3-[(4-chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide
AS1949490, competitive inhibitor of SHIP2
insulin receptor tyrosine kinase substrate
i.e. IRTKS, i.e. BAI1-associated protein 2-like 1, i.e. BAIAP2L1. Interacts with SHIP2 to suppress its activity
-
N-(4-[[(4-chlorophenyl)methoxy]methyl]pyridin-2-yl)-3-phenylpropanamide
-
N-[4-[(4-chlorophenyl)methoxy]pyridin-2-yl]-2-(2,6-difluorophenyl)acetamide
-
phosphatidylinositol 4,5-bisphosphate
-
strong inhibition at low micromolar concentrations
phosphatidylinositol 4-phosphate
-
inhibition at low micromolar concentrations
additional information
an amine tethered to the quinoline core is required for SHIP inhibition
-
additional information
SHIP1 is autoinhibited with the N-terminal Src homology 2 domain playing a critical role in suppressing phosphatase activity
-
additional information
-
the enzyme is insensitive to N-ethylmaleimide, InsPh and 2,3-bisphosphoglycerate
-
additional information
-
N-ethylmaleimide, orthophosphate, 4-nitrophenylphosphate, glycerolbisphosphate, inositol hexakisphosphate and (1R,2R,4R)-cyclohexane-1,2,4-trismethylenesulfonate are without significant effect on the enzyme activity
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate
1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate directly interacts with the pleckstrin homology-related (PHR) domain to trigger allosteric activation
immune receptor-derived tyrosine-phosphorylated peptide
the presence of an immune receptor-derived tyrosine-phosphorylated peptide added in solution or membrane tethered, SHIP1-lipid phosphatase activity is robustly stimulated
-
phosphoinositide
phosphoinositide-induced transition to a high activity state of the enzyme increases phosphatase activity up to 10-15fold
phosphoinositide lipid
binding of its pleckstrin homology-related (PHR) domain to specific phosphoinositide lipids in the cell membrane enhances catalytic activity
-
additional information
-
SHIP2 enzyme activity with phosphatidylinositol 3,4,5-trisphosphate is 11fold stimulated in the presence of 0.02 mM vesicles of phosphatidylserine. 0.2 mM vesicles of phosphatidylcholine stimulate 2fold phosphatidylinositol 3,4,5-trisphosphate phosphatase activity of SHIP2
-
additional information
binding of the PHR domain of the enzyme to specific phosphoinositide lipids in the cell membrane enhances catalytic activity
-
additional information
-
vinexin beta does not affect PtdIns(3,4,5)P3 5-phosphatase activity of SHIP2
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
0.001
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
-
in the presence of 5 mM MgCl2, 0.5 mM EGTA, 50 mM Tris, pH 7.4, temperature not specified in the publication
0.043
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
wild type enzyme, at pH 7.0 and 23°C
0.059
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
mutant enzyme R649A, at pH 7.0 and 23°C
0.061
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
mutant enzyme F593D/L597D, at pH 7.0 and 23°C
0.088
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
-
wild type enzyme, at pH 7.5 and 25°C
0.0316
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
-
mutant enzyme D360A/N362A, at pH 7.5 and 25°C
0.0738
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
-
wild type enzyme, at pH 7.5 and 25°C
0.1
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
-
in the presence of 5 mM MgCl2, 0.5 mM EGTA, 50 mM Tris, pH 7.4, temperature not specified in the publication
0.082
Inositol 1,3,4,5-tetrakisphosphate
mutant enzyme F593D/L597D, at pH 7.0 and 23°C
0.098
Inositol 1,3,4,5-tetrakisphosphate
wild type enzyme, at pH 7.0 and 23°C
0.126
Inositol 1,3,4,5-tetrakisphosphate
mutant enzyme R649A, at pH 7.0 and 23°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
0.69
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
wild type enzyme, at pH 7.0 and 23°C
1.35
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
mutant enzyme R649A, at pH 7.0 and 23°C
4.44
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
mutant enzyme F593D/L597D, at pH 7.0 and 23°C
57.5
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
-
wild type enzyme, at pH 7.5 and 25°C
28.2
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
-
mutant enzyme D360A/N362A, at pH 7.5 and 25°C
140.5
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
-
wild type enzyme, at pH 7.5 and 25°C
1.2
Inositol 1,3,4,5-tetrakisphosphate
mutant enzyme F593D/L597D, at pH 7.0 and 23°C
1.32
Inositol 1,3,4,5-tetrakisphosphate
wild type enzyme, at pH 7.0 and 23°C
1.64
Inositol 1,3,4,5-tetrakisphosphate
mutant enzyme R649A, at pH 7.0 and 23°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
kcat/KM VALUE [1/mMs-1]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
653
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate
-
wild type enzyme, at pH 7.5 and 25°C
892
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
-
mutant enzyme D360A/N362A, at pH 7.5 and 25°C
1900
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
-
wild type enzyme, at pH 7.5 and 25°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
0.03
(2R)-2-[(S)-hydroxy(2-phenylbenzo[h]quinolin-4-yl)methyl]piperidin-1-ium
pH and temperature not specified in the publication
0.063
(2R)-2-[(S)-[5,7-dichloro-3-adamantyl)naphthalen-1-yl](hydroxy)methyl]piperidin-1-ium
pH and temperature not specified in the publication
0.5
2-[1-[(2-chlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
pH and temperature not specified in the publication
0.00057
3-[(2,4-dichlorophenyl)methoxy]-N-[(2,6-difluorophenyl)methyl]thiophene-2-carboxamide
pH and temperature not specified in the publication
0.00062
3-[(4-chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide
pH and temperature not specified in the publication
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
IMAGE
0.03
(2R)-2-[(S)-hydroxy(2-phenylbenzo[h]quinolin-4-yl)methyl]piperidin-1-ium
Homo sapiens
pH and temperature not specified in the publication
0.063
(2R)-2-[(S)-[5,7-dichloro-3-adamantyl)naphthalen-1-yl](hydroxy)methyl]piperidin-1-ium
Homo sapiens
pH and temperature not specified in the publication
0.03
2-(1-(2,4-dichlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.051 - 0.058
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
0.011 - 0.014
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
-
0.5
2-[1-[(2-chlorophenyl)methyl]-2-methyl-5-(methylsulfanyl)-1H-indol-3-yl]ethan-1-aminium
Homo sapiens
pH and temperature not specified in the publication
0.00057
3-[(2,4-dichlorophenyl)methoxy]-N-[(2,6-difluorophenyl)methyl]thiophene-2-carboxamide
Homo sapiens
pH and temperature not specified in the publication
0.00062
3-[(4-chlorophenyl)methoxy]-N-[(1S)-1-phenylethyl]thiophene-2-carboxamide
Homo sapiens
pH and temperature not specified in the publication
0.000061
6,6'-difluoro biphenyl 3,3',4,4'-tetrakisphosphate
Homo sapiens
pH 7.3, 25°C
-
0.051
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.058
2-(1-(4-Bromobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.011
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.014
2-(1-(4-chlorobenzyl)-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.055
2-(1-benzyl-2-methyl-1H-indol-3-yl) ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.062
2-(1-benzyl-2-methyl-1H-indol-3-yl) ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.012
2-(1-benzyl-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
0.013
2-(1-benzyl-2-methyl-5-(methylthio)-1H-indol-3-yl)ethanaminium chloride
Homo sapiens
pH 7.4, 37°C
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
pI VALUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ORGANISM
COMMENTARY
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
-
-
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
SOURCE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY
GeneOntology No.
LITERATURE
SOURCE
Highest Expressing Human Cell Lines
Cell Line LinksPlease wait a moment until the data is sorted. This message will disappear when the data is sorted.
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
drug target
therapeutic target for pathophysiologies dependent on PtdIns(3,4,5)P3 and PtdIns(3,4)P2. The study reveals a potentially druggable allosteric site on the enzyme
malfunction
metabolism
physiological function
additional information
malfunction
-
cell adhesion to collagen-I-coated dishes is decreased in SHIP2-deicient MEF cells compared with wild type cells
malfunction
-
depletion of SHIP 5'-phosphatases increases neutrophil wound attraction and random motility through a PI3K-dependent pathway. Ectopic expression of the SHIP1 phosphatase domain impairs neutrophil migration
malfunction
enzyme deficiency leads to myeloproliferation and B-cell lymphoma in mice
malfunction
isoform SHIP2 inhibition or knockdown inhibits cell migration and reduces phosphorylated protein kinase B levels, resulting in sensitivity to chemotherapeutics
malfunction
enzyme mutations are associated with opsismodysplasia. Mice expressing a germline catalytically inactive SHIP2 mutant protein are viable, but have defects in the development of muscle, adipose tissue and the female genital tract, as well as in somatic growth
malfunction
disruption of the enzyme-Mena interaction in cancer cells leads to attenuated capacity for extracellular matrix degradation and invasion in vitro, as well as reduced metastasis in vivo
malfunction
apoptosis in MDA-MB-231 cells is increased in SHIP2-depleted cells as compared to control cells
malfunction
enzyme depletion inhibits cell migration of glioblastoma cells
malfunction
the absence of SHIP1 has no significant impact on thrombin-induced Akt or Erk1/2 activation, but it selectively affects the RhoA/Rho-kinase pathway and myosin IIA relocalization to the cytoskeleton
malfunction
Ship2-null mice are resistant to high-fat diet induced obesity and show increased insulin sensitivity and glucose tolerance. Transgenic overexpression causes increased body weight and reduced glucose tolerance.SHIP2 overexpression promotes breast tumourigenesis via AKT-dependent and independent mechanisms
metabolism
the enzyme has been heavily implicated in serious diseases such as cancer and type 2 diabetes
physiological function
-
the Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in epidermal growth factor-stimulated COS-7 cells
physiological function
-
SHIP is involved in platelet activation evoked by thrombin
physiological function
isoforms SHIP2 and SHIP1 have a different hierarchy of binding SH3-domain containing proteins
physiological function
-
PR130/Balpha1 and SHIP2 partially colocalize in untreated HeLa cells, and both translocate to the cell membrane on epidermal growth factor stimulation. Protein phosphatase 2A PR130/Balpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor-induced epidermal growth factor receptor degradation sustaining epidermal growth factor-mediated signaling
physiological function
-
SHIP2 interaction with vinexin alpha promotes the localization of SHIP2 at the periphery of the cells leaving its catalytic site intact. SHIP2 is active both as a PtdIns(3,4,5)P3 5-phosphatase and as a modulator of focal contact formation
physiological function
-
SHIP phosphatases serve as a brake that limit neutrophil motility and inflammation, at least in part through their effects on PI3K signaling
physiological function
the enzyme acts as a negative regulator of immune response and haematopoietic progenitor cell proliferation/survival, and as an inducer of cellular apoptosis. Isoform SHIP-2 is a negative regulator of glucose homeostasis and is involved in the maturation and activation of mast cells as well as in phagocytosis directed by Fc receptors for immunoglobulin G, thus regulating allergic reactions and antibacterial defense
physiological function
isoform SHIP2 functions as oncogene in colorectal cancer by regulating protein kinase B activation
physiological function
the enzyme acts as a negative regulator of immune response and haematopoietic progenitor cell proliferation/survival, and as an inducer of cellular apoptosis. Isoform SHIP-1 is also implicated both as a haematopoietic tumour suppressor and activator
physiological function
overexpression of the wild-ype SHIP2 gene leads to a higher total lipid content (28%) compared to control, whereas overexpression of the dominant negative SHIP2 gene reduces total lipid content in oleate treated cells by 40%. Overexpression of SHIP2 wild-type also leads to a significant increase in both secretion of apoB100 containing lipoproteins and de novo lipogenesis. Overexpression of the SHIP2 dominant negative gene prevents oleate-induced de novo lipogenesis and secretion of apoB100 containing lipoproteins in HepG2 cells
physiological function
isoform SHIP2 regulates Akt signalling in metabolic tissues
physiological function
high glucose induces SHIP2 mRNA and protein levels in HepG2 cells. Overexpression of a dominant negative mutant SHIP2 ameliorates high glucose-induced de novo lipogenesis and secretion of apoB containing lipoprotein in HepG2 cells. Overexpression of the SHIP2 dominant negative mutant decreases high glucose-induced apoB containing lipoproteins secretion via reduction in reactive oxygen species generation, JNK phosphorylation and Akt activation. AMPK/mTOR/SREBP1 is the signaling pathway that mediates the effects of SHIP2 modulation on hepatic de novo lipogenesis
physiological function
the enzyme SHIP2 recruits Mena, but not vasodilator-stimulated phosphoprotein, to invadopodia
physiological function
-
the enzyme's activity controls 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate binding by RAP1 and, thus, transcriptional silencing of variant surface glycoprotein genes
physiological function
isoform SHIP1 inhibits haematopoietic cell proliferation, inhibits Akt signalling and regulates immune cell function in vitro and in vivo
physiological function
1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate (PI(3,4,5)P3) is a key lipid second messenger controlling the recruitment of signaling proteins to the plasma membrane, thereby regulating a plethora of cellular events, including proliferation, growth, apoptosis, and cytoskeletal rearrangements. SHIP2, alongside PI3K and PTEN, regulates PI(3,4,5)P3 levels at the plasma membrane
physiological function
SHIP2 promotes neutrophil chemotaxis and recruitment
physiological function
lipid-independent function for SHIP1 in the regulation of the contractile cytoskeleton and integrin dynamics in platelets
physiological function
SHIP2 regulates 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate levels at the plasma membrane and is heavily implicated in serious diseases such as cancer and type 2 diabetes
physiological function
in cell polarization and migration, SHIP2 serves as a RhoA effector for manipulating the level of phosphatidylinositol 3,4,5-trisphosphate. The construct, SHIP2(176-298) is sufficient for binding with the GTP-bound RhoA
physiological function
pro-tumourigenic role in breast cancer. SHIP2 may have a context-specific role in regulating cancer growth, depending on the tissue-specific expression of its interacting proteins as well as whether these protein-protein interactions are pro- or anti-tumourigenic
physiological function
dephosphorylation of phosphatidylinositol 3,4,5-trisphosphate
additional information
the PHR domain acts as an allosteric module regulating the catalytic activity of SHIP2 in response to specific phosphoinositide levels in the cell membrane
additional information
localization of the central catalytic domain of SHIP1 is insensitive to dynamic changes in 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate and phosphatidylinositol-(3,4)-bisphosphate both in vitro and in vivo
Show AA Sequence and Transmembrane Helices (5191 entries)
Longer loading times are possible. Please use the AA Sequence and Transmembrane Helices Search for a specific query.
Longer loading times are possible. Please use the AA Sequence and Transmembrane Helices Search for a specific query.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PDB
SCOP
CATH
UNIPROT
ORGANISM
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
145000
150000
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
homodimer
SHIP2(118-298) and SHIP2(176-298), two truncated proteins harboring the RhoA-binding domain (RBD)
?
x * 52688, a fragment of human SHIP2 containing the phosphatase domain and a region proposed to resemble a C2 domain, calculated from amino acid sequence
?
x * 52685, a fragment of human SHIP2 containing the phosphatase domain and a region proposed to resemble a C2 domain, electrospray ionization mass spectrometry
?
x * 500005, a fragment of human SHIP2 containing the phosphatase domain and a region proposed to resemble a C2 domain, SDS-PAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
phosphoprotein
phosphoprotein
-
in COS-7 cells, SHIP2 is tyrosine-phosphorylated at least at two separated tyrosine phosphorylation sites in response to epidermal growth factor
phosphoprotein
-
thrombin stimulation induces a tyrosine phosphorylation of SHIP
phosphoprotein
isoforms SHIP2 and SHIP1 are constitutively tyrosine phosphorylated in chronic myelogenous leukemia progenitor cells
phosphoprotein
isoforms SHIP2 and SHIP1 are constitutively tyrosine phosphorylated in chronic myelogenous leukemia progenitor cells. Stimulation of human hematopoietic growth factor responsive cell lines with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor leads to rapid tyrosine phosphorylation of SHIP2 and its resulting association with src homologous and collagen gene
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
a fragment of human SHIP2 containing the phosphatase domain and a region proposed to resemble a C2 domain is crystallized by the hanging drop vapor diffusion method, using 0.1 M Bis-Tris propane pH 7.0, 0.2 M NaNO3, 20% (w/v) PEG 3350, 0.025 % (w/v) CH2Cl2, 2 mM Tris(2-carboxyethyl)phosphine
using 100 mM Bis-Tris propane, pH 7.0, 0.2 M NaNO3, 20% (w/v) PEG3350, 0.025% (v/v) CH2Cl2
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
R649A
the mutation removes C2 domain effects on inositol 1,3,4,5-tetrakisphosphate but not 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate kinetics
D360A/N362A
-
the mutations completely eliminate enzyme activity toward 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate and significantly decrease the dephosphorylation activity of the enzyme for 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate
additional information
characterization of SHIP1 truncation mutants reveals that both the N-terminal SH2 domain and the disordered C-terminal tail limit SHIP1 phosphatase activity but to different extents
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
GST resin column chromatography, Source 15S column chromatography, and Superdex 200 gel filtration
HiTrap S column chromatography, phosphocellulose column chromatography, heparin-HiTrap column chromatography, Q-HiTrap column chromatography, and S-300 gel filtration
-
SHIP2(118-298) and SHIP2(176-298), two truncated proteins harboring the RhoA-binding domain (RBD) are designed, expressed, and purified
the enzyme is co-purified with the p85/pll0 form of PI 3-kinase, by Q-Sepharose column chromatography, S-Sepharose column chromatography, hydroxyapatite column chromatography and Mono S column chromatography
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
expressed in COS-7 cells
expressed in Escherichia coli BL21(DE3) cells
expression in Escherichia coli, SHIP2(118-298) and SHIP2(176-298), two truncated proteins harboring the RhoA-binding domain (RBD), exist as homo-dimers in solution by multi-angle light scattering
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
enzyme expression is increased in colorectal cancer tissue in comparison to adjacent normal tissue
increased in primary breast tumours, which correlates with invasive disease and reduced survival
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
APPLICATION
ORGANISM
UNIPROT
COMMENTARY
LITERATURE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Jackson, S.P.; Schoenwaelder, S.M.; Matzaris, M.; Brown, S.; Mitchell, C.A.
Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase
EMBO J.
14
4490-4500
1995
Homo sapiens
brenda
Vandeput, F.; Backers, K.; Villeret, V.; Pesesse, X.; Erneux, C.
The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity
Cell. Signal.
18
2193-2199
2006
Homo sapiens
brenda
Drayer, A.L.; Pesesse, X.; De Smedt, F.; Woscholski, R.; Parker, P.; Erneux, C.
Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
Biochem. Biophys. Res. Commun.
225
243-249
1996
Homo sapiens
brenda
Drayer, A.; Pesesse, X.; De Smedt, F.; Communi, D.; Moreau, C.; Erneux, C.
The family of inositol and phosphatidylinositol polyphosphate 5-phosphatases
Biochem. Soc. Trans.
24
1001-1005
1996
Homo sapiens, Rattus norvegicus
brenda
Wisniewski, D.; Strife, A.; Swendeman, S.; Erdjument-Bromage, H.; Geromanos, S.; Kavanaugh, W.M.; Tempst, P.; Clarkson, B.
A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells
Blood
93
2707-2720
1999
Homo sapiens (Q92835), Homo sapiens (O15357)
brenda
Zwaenepoel, K.; Goris, J.; Erneux, C.; Parker, P.J.; Janssens, V.
Protein phosphatase 2A PR130/Balpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling
FASEB J.
24
538-547
2010
Homo sapiens
brenda
Paternotte, N.; Zhang, J.; Vandenbroere, I.; Backers, K.; Blero, D.; Kioka, N.; Vanderwinden, J.M.; Pirson, I.; Erneux, C.
SHIP2 interaction with the cytoskeletal protein Vinexin
FEBS J.
272
6052-6066
2005
Mus musculus
brenda
Pesesse, X.; Moreau, C.; Drayer, A.L.; Woscholski, R.; Parker, P.; Erneux, C.
The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity
FEBS Lett.
437
301-303
1998
Homo sapiens
brenda
Lioubin, M.N.; Algate, P.A.; Tsai, S.; Carlberg, K.; Aebersold, A.; Rohrschneider, L.R.
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity
Genes Dev.
10
1084-95
1996
Homo sapiens
brenda
Woscholski, R.; Waterfield, M.D.; Parker, P.J.
Purification and biochemical characterization of a mammalian phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase
J. Biol. Chem.
270
31001-31007
1995
Rattus norvegicus
brenda
Giuriato, S.; Payrastre, B.; Drayer, A.L.; Plantavid, M.; Woscholski, R.; Parker, P.; Erneux, C.; Chap, H.
Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets
J. Biol. Chem.
272
26857-26863
1997
Homo sapiens
brenda
Woscholski, R.; Finan, P.M.; Radley, E.; Totty, N.F.; Sterling, A.E.; Hsuan, J.J.; Waterfield, M.D.; Parker, P.J.
Synaptojanin is the major constitutively active phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase in rodent brain
J. Biol. Chem.
272
9625-9628
1997
Rattus norvegicus
brenda
Pesesse, X.; Dewaste, V.; De Smedt, F.; Laffargue, M.; Giuriato, S.; Moreau, C.; Payrastre, B.; Erneux, C.
The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells
J. Biol. Chem.
276
28348-28355
2001
Homo sapiens
brenda
Ooms, L.M.; Dyson, J.M.; Kong, A.M.; Mitchell, C.A.
Analysis of phosphatidylinositol 3,4,5 trisphosphate 5-phosphatase activity by in vitro and in vivo assays
Methods Mol. Biol.
462
223-239
2009
Chlorocebus aethiops
brenda
Damen, J.E.; Liu, L.; Rosten, P.; Humphries, R.K.; Jefferson, A.B.; Majerus, P.W.; Krystal, G.
The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase
Proc. Natl. Acad. Sci. USA
93
1689-1693
1996
Mus musculus
brenda
Kuehbacher, A.; Dambournet, D.; Echard, A.; Cossart, P.; Pizarro-Cerda, J.
Phosphatidylinositol 5-phosphatase oculocerebrorenal syndrome of Lowe protein (OCRL) controls actin dynamics during early steps of Listeria monocytogenes infection
J. Biol. Chem.
287
13128-13136
2012
Danio rerio
brenda
Ijuin, T.; Takenawa, T.
Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP)
J. Biol. Chem.
287
6991-6999
2012
Mus musculus
brenda
Tu, W.J.; Liu, X.Y.; Dong, H.; Yu, Y.; Wang, Y.; Chen, H.
Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1: a meaningful and independent marker to predict stroke in the Chinese population
J. Mol. Neurosci.
52
507-514
2014
Homo sapiens
brenda
Ramos, A.R.; Elong Edimo, W.; Erneux, C.
Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved
Adv. Biol. Regul.
67
40-48
2018
Homo sapiens (O15357)
brenda
Gorgani-Firuzjaee, S.; Adeli, K.; Meshkani, R.
Inhibition of SH2-domain-containing inositol 5-phosphatase (SHIP2) ameliorates palmitate induced-apoptosis through regulating Akt/FOXO1 pathway and ROS production in HepG2 cells
Biochem. Biophys. Res. Commun.
464
441-446
2015
Homo sapiens (O15357)
brenda
Eramo, M.J.; Mitchell, C.A.
Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases
Biochem. Soc. Trans.
44
240-252
2016
Homo sapiens (Q92835), Homo sapiens (O15357)
brenda
Russo, C.M.; Adhikari, A.A.; Wallach, D.R.; Fernandes, S.; Balch, A.N.; Kerr, W.G.; Chisholm, J.D.
Synthesis and initial evaluation of quinoline-based inhibitors of the SH2-containing inositol 5-phosphatase (SHIP)
Bioorg. Med. Chem. Lett.
25
5344-5348
2015
Homo sapiens (Q92835)
brenda
Thomas, M.P.; Erneux, C.; Potter, B.V.
SHIP2 structure, function and inhibition
ChemBioChem
18
233-247
2017
Homo sapiens (O15357)
brenda
Le Coq, J.; Camacho-Artacho, M.; Velazquez, J.V.; Santiveri, C.M.; Gallego, L.H.; Campos-Olivas, R.; Doelker, N.; Lietha, D.
Structural basis for interdomain communication in SHIP2 providing high phosphatase activity
eLife
6
e26640
2017
Homo sapiens (O15357)
brenda
Gorgani-Firuzjaee, S.; Meshkani, R.
SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells
Free Radic. Biol. Med.
89
679-689
2015
Homo sapiens (O15357)
brenda
Rajadurai, C.V.; Havrylov, S.; Coelho, P.P.; Ratcliffe, C.D.; Zaoui, K.; Huang, B.H.; Monast, A.; Chughtai, N.; Sangwan, V.; Gertler, F.B.; Siegel, P.M.; Park, M.
5-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion
J. Cell Biol.
214
719-734
2016
Homo sapiens (O15357)
brenda
Elong Edimo, W.; Ghosh, S.; Derua, R.; Janssens, V.; Waelkens, E.; Vanderwinden, J.M.; Robe, P.; Erneux, C.
SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells
J. Cell Sci.
129
1101-1114
2016
Homo sapiens (O15357)
brenda
Ghosh, S.; Scozzaro, S.; Ramos, A.R.; Delcambre, S.; Chevalier, C.; Krejci, P.; Erneux, C.
Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells
J. Cell Sci.
131
jcs216408
2018
Homo sapiens (O15357)
brenda
Cestari, I.; McLeland-Wieser, H.; Stuart, K.
Nuclear phosphatidylinositol 5-phosphatase is essential for allelic exclusion of variant surface glycoprotein genes in trypanosomes
Mol. Cell. Biol.
39
e00395-18
2019
Trypanosoma brucei
brenda
Dempke, W.C.M.; Uciechowski, P.; Fenchel, K.; Chevassut, T.
Targeting SHP-1, 2 and SHIP pathways a novel strategy for cancer treatment?
Oncology
95
257-269
2018
Homo sapiens (Q92835), Homo sapiens (O15357)
brenda
Hoekstra, E.; Das, A.M.; Willemsen, M.; Swets, M.; Kuppen, P.J.; van der Woude, C.J.; Bruno, M.J.; Shah, J.P.; Ten Hagen, T.L.; Chisholm, J.D.; Kerr, W.G.; Peppelenbosch, M.P.; Fuhler, G.M.
Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation
Oncotarget
7
73525-73540
2016
Homo sapiens (O15357)
brenda
Le Coq, J.; Heredia Gallego, L.; Lietha, D.
Expression, purification, crystallisation and X-ray crystallographic analysis of a truncated form of human Src homology 2 containing inositol 5-phosphatase 2
Protein J.
35
225-230
2016
Homo sapiens (O15357)
brenda
Le Coq, J.; Lopez Navajas, P.; Rodrigo Martin, B.; Alfonso, C.; Lietha, D.
A new layer of phosphoinositide-mediated allosteric regulation uncovered for SHIP2
FASEB J.
35
e21815
2021
Homo sapiens (O15357)
brenda
Michael, M.; McCormick, B.; Anderson, K.E.; Karmakar, U.; Vermeren, M.; Schurmans, S.; Amour, A.; Vermeren, S.
The 5-phosphatase SHIP2 promotes neutrophil chemotaxis and recruitment
Front. Immunol.
12
671756
2021
Mus musculus (Q6P549)
brenda
Wu, C.; Cui, X.; Huang, L.; Shang, X.; Wu, B.; Wang, N.; He, K.; Han, Z.
Irtks promotes insulin signaling transduction through inhibiting ship2 phosphatase activity
Int. J. Mol. Sci.
20
2834
2019
Homo sapiens (O15357)
brenda
Csolle, M.P.; Ooms, L.M.; Papa, A.; Mitchell, C.A.
PTEN and other PtdIns(3,4,5)P3 lipid phosphatases in breast cancer
Int. J. Mol. Sci.
21
9189
2020
Mus musculus (Q6P549)
brenda
Severin, S.; Consonni, A.; Chicanne, G.; Allart, S.; Payrastre, B.; Gratacap, M.P.
SHIP1 controls internal platelet contraction and alphaIIbbeta3 integrin dynamics in early platelet activation
Int. J. Mol. Sci.
24
958
2023
Mus musculus (Q9ES52)
brenda
Waddell, G.L.; Drew, E.E.; Rupp, H.P.; Hansen, S.D.
Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase
J. Biol. Chem.
299
105022
2023
Homo sapiens (Q92835)
brenda
Whitfield, H.; Hemmings, A.M.; Mills, S.J.; Baker, K.; White, G.; Rushworth, S.; Riley, A.M.; Potter, B.V.L.; Brearley, C.A.
Allosteric site on SHIP2 identified through fluorescent ligand screening and crystallography a potential new target for intervention
J. Med. Chem.
64
3813-3826
2021
Homo sapiens (O15357)
brenda
Fernandes, S.; Meyer, S.T.; Shah, J.P.; Adhikari, A.A.; Kerr, W.G.; Chisholm, J.D.
N1-Benzyl tryptamine Pan-SHIP1/2 inhibitors synthesis and preliminary biological evaluation as anti-tumor agents
Molecules
27
8451
2022
Homo sapiens (Q92835), Homo sapiens (O15357)
brenda
Zhou, H.; Yue, X.; Wang, Z.; Li, S.; Zhu, J.; Yang, Y.; Liu, M.
Expression, purification and characterization of the RhoA-binding domain of human SHIP2 in E. coli
Protein Expr. Purif.
180
105821
2021
Homo sapiens (O15357)
brenda
EXTERNAL LINKS (specific for EC-Number 3.1.3.86)
html completed
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2026.1 (March 2026)
About BRENDA
Social media
Help
Survey
Download
Contribution
Legal
Curated at
Member of
![DSMZ Digital Diversity]()
![Global Core Biodata Resource]()
![ELIXIR Core Data Resource]()
![German Network for Bioinformatics Infrastructure]()
